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INTRODUCTION
Starvation and weight loss are among the main
causes of female reproductive disorders. Currently,
a lot of women wish to become slim that often re-
sults in amenorrhea. However, the neurological
relation between feeding behavior and reproductive
habits has not yet been completely clarified.
Among the known feeding regulators, some ap-
pear to influence gonadotropin secretion. Starvation
stimulates the expression of orexin, which is one
of the orexinergic peptides, in the lateral hypotha-
lamic area (LHA) or the feeding center (1). Orexin
neurons project their fibers to the arcuate nucleus
(ARC), which contains neuropeptide Y (NPY) neu-
rons, and to the paraventricular nucleus (PVN),
which contains corticotrophin-releasing hormone
(CRH) neurons (2, 3). NPY appeared to mediate the
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orexinergic effect of orexin, because this effect was
blocked after co-administration with NPY Y1 recep-
tor antagonist in rats (4). However, we found that
orexin suppressed the hypothalamic pulsatile secre-
tion of gonadotropin-releasing hormone (GnRH) in
ovariectomized (OVX) rats (5). We used OVX rats,
because it may be affected by ovarian factors such
as estradiol, progesterone, inhibin and activin.
Orexin might directly regulate GnRH secretion
because orexin neurons project their fibers into the
preoptic area and into the group of septic nucleus
that contain the GnRH cell bodies in rodents. In ad-
dition, orexin neurons project into ARC and PVN
and indirectly suppress GnRH secretion via sev-
eral neural pathways involving NPY, CRH, and
proopiomelanocortin (POMC) (6) ; further, orexin
suppresses the pulsatile secretion of luteinizing hor-
mone (LH) via β -endorphin and CRH as we have
reported in our previous studies (7, 8). However,
the mechanism of orexin-mediated suppression of
GnRH secretion remains to be completely clarified.
In this study, we investigated whether NPY plays a
role in the orexin-mediated suppression of GnRH
secretion in OVX rats.
MATERIALS AND METHODS
Animals
Eight-week-old female Wistar rats (weight, 160-
200 g) were purchased from Charles River Inc.,
Yokohama, Japan). The rats were housed in a room
with controlled lighting (light period, 0800-2030)
and temperature (24), and they were allowed ad
libitum access to standard laboratory pellets of rat
chow and tap water. All animal experiments were
conducted in accordance with the ethical standards
of Animal Care and Use Committee of the University
of Tokushima. All rats were bilaterally ovariec-
tomized under intraperitoneal anesthesia with pen-
tobarbital sodium (40 mg/kg body weight) and
used for the experiments 2 weeks later.
Implantation of a brain cannula and atrial cannu-
lation
At 2 weeks after ovariectomy, a brain cannula
was implanted under intraperitoneal pentobarbital
anesthesia (50 mg/kg body weight). A 23-gauge
stainless-steel tube guide cannula (length, 20 mm ;
outer diameter, 0.64 mm ; inner diameter, 0.39 mm)
was implanted into the third ventricle (3V) using
the stereotaxic coordinates according to the atlas of
Paxinos and Watson (9). A sterile 29-gauge stain-
less-steel obturator with a polyethylene cap (length,
20 mm ; outer diameter, 0.33 mm ; inner diameter,
0.17 mm) was inserted into the guide cannula to
ensure that the cannula remained patent. One week
after brain cannulation, the rats were anesthetized
intraperitoneally using a mixture of ketamine and
xylazine (20 : 5 mg/kg body weight, ip), and a silas-
tic tube (outer diameter, 1.0 mm ; inner diameter,
0.5 mm ; Kaneka Medics, Tokyo, Japan) was in-
serted into the external jugular vein and sewn into
the skin after confirming its positioning in the right
atrium (10). The tube was rinsed with heparinized
saline (10,000 U/l saline) and threaded to an exit
at the back of the neck. On the next day, the intra-
atrial cannula was rinsed and connected to a long
polyethylene tube containing heparinized saline. A
steel pin was inserted into the open end of this tube,
and the tube was led outside the cage to permit
rapid blood sampling without handling the rats.
Feeding experiment
On the day after atrial cannulation, 3 nmol of
orexin A (Peptide Institute, Inc., Osaka, Japan) dis-
solved in 5 μl of distilled water or 5 μl saline as con-
trol (Group C) were administered intracerebroven-
tricularly (icv) during the dark period ; 5 μl of NPY
antiserum (Group ON, GroupN)(NPY-Ab ; Peptide
Institute, Inc., Osaka, Japan) or normal rabbit se-
rum (Group O) (Wako Pure Chemical Industries,
Ltd., Osaka, Japan) were administered icv 10 min
before the injection of orexin A using a Hamilton
microsilinge. After their rats were fed freely in in-
dividual cage in the darkness, we calculated the
amount of food consumption in the next 2 h. The
reduction in food weight was measured using a
digital scale (HL-200 ; Tokyo, Japan) at 0 and 2 h
after injection of saline or orexin A. In the feeding
experiment, the rats were divided into the following
4 groups : Group C (saline, n=9), Group O (normal
rabbit serum+orexin A, n=8), Group ON (NPY-Ab+
orexin A, n=8) and Group N (NPY-Ab+saline, n=4).
Reproductive experiment
Three nmol of orexin A dissolved in 5 μl of dis-
tilled water or 5 μl of saline (Group C) was admin-
istered into the 3V ; 5 μl of NPY-Ab (Group ON) or
normal rabbit serum (Group O) were administered
10 min before the injection of orexin A. In the re-
productive experiment, the rats were divided into
the following 3 groups : Group C (saline, n=9),
Group O (normal rabbit serum+orexin A, n=8), and
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Group ON (NPY-Ab+orexin A, n=8).
Blood samples were collected through the intra-
atrial cannula just before icv administration and then
at 6-min intervals over the next 2 h. After each sam-
pling, an equal volume of heparinized saline was in-
jected. Blood samples were centrifuged and the ob-
tained plasma samples were stored at -40until
the measurement of LH concentrations by radioim-
munoassay (RIA).
RIA for the measurement of LH
Serum LH concentration was measured using a
double-antibody rat RIA kit for LH (RPA552 ; GE
Healthcare UK, Bucks, UK). The minimum detect-
able concentration was assayed at 0.09 ng/tube, and
the intra- and interassay coefficients of variation
(CVs) were 6.5% and 6.6%, respectively.
Statistical analysis
LH pulses were defined and identified using the
established criteria, as described by Gallo (11) and
DePaolo et al . (12). Further, CV was calculated
using the LH concentrations in the ascending and
descending phases of a suspected pulse. A pulse
was assumed to have occurred if the CV was greater
than twice the CV of the LH standard solution,
which corresponded to the mean LH levels in the
suspected pulse. The pulse amplitude indicated the
difference between the peak and baseline values of
LH concentrations. The mean LH concentration,
pulse frequency (number of pulses during the 2-h
period), and mean pulse amplitude were calculated
for each animal. This method has been shown to re-
veal differences in the parameters of pulsatile hor-
mone release of the groups, and these differences
are similar to those obtained by cluster algorithm
(13). The data were analyzed using one-way analy-
sis of variance and subsequently by Fisher’s pro-
tected least significant difference test. All statis-
tical analyses were performed using StatView for
Macintosh version 5.0 (SAS Institute, Cary, NC,
USA). The differences were considered statistically
significant at the level of p0.05. All results are pre-
sented as meanstandard error of the mean, and
determined using 8 or 9 samples for each group as
indicated.
RESULTS
The profiles of rats in each group just before the
icv administration are shown in Table 1. Those
groups did not show significant differences in body
weight or basal LH levels.
The results of statistical analysis for food intakes
after icv administration are shown in Figure 1. The
2-h food intake in Group O after icv administration
during the light period was significantly larger than
that in Group C (p0.05). Food intake in Group
ON was significantly lesser than that in Group O
(p0.05). NPY-Ab did not affect food intake, but
the orexin A-mediated stimulation of food intake
was not observed after pretreatment with NPY-Ab.
The changes in serum LH concentration in three
groups are shown in Figure 2 and Table 2. Group O
Figure 1 : Two-hour food intake after the intracerebroventricu-
lar (icv) administration in ovariectomized rats. The values are ex-
pressed as the meanstandard error of mean (SEM). Group C
(saline : control), Group O (NRS+orexin A), Group ON (NPY
antibody+orexin A), Group N (NPY antibody+saline). * : p0.05
compared with Group O. (one-way analysis of variance followed
by Fisher’s protected least significant difference test).
Table 1 Baseline Data of Rats
Group Number of rats Body weight (g) Basal LH level (μg/l)*
Group C (saline) 9 2864.61 8.462.61
Group O (NRS+orexin A) 8 2774.96 8.242.40
Group O (NRS+orexin A) 8 2774.96 8.242.40
Group N (NPY Ab+saline) 4 2845.27 -
Note. Values are expressed as meansSEM.
* Basal LH level denotes the serum LH concentration just before icv administration of orexin A or saline.
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showed significantly lower serum LH levels than
Group C at several time points after orexin A admini-
stration ; however, there was no significant differ-
ence between Group ON, in which NPY-Ab was co-
administered with orexin A, and Group C.
The representative LH secretion profiles of each
group are shown in Figure 3. In the Group C rat,
the pulsatile secretion of LH was frequently ob-
served for 2 h. In the Group O rat, which was in-
jected with only orexin A, plasma LH level de-
creased rapidly after icv administration and the fre-
quency of pulsatile LH secretion appeared to be
lower as compared to that of the Group C rat. In the
Group ON rat, which was co-administered NPY-Ab
and orexin A, pulsatile LH secretion appeared fre-
quently, similar to that observed in the Group C rat.
The results of statistical analysis of pulsatile LH
secretion are shown in Figure 4. Administration of
orexin A (Group O) significantly reduced the mean
LH concentration and the pulse frequency (Group O
vs Group C, p0.01, respectively). Co-administration
of NPY-Ab with orexin A (Group ON) significantly
restored the suppression of mean LH concentra-
tion and pulse frequency in Group O (Group ON
Figure 2 : Changes in the serum concentrations of LH in each group for 120 min after injection. Values are expressed as the
meanstandard error of mean (SEM). a : p0.05 vs Group C, * : p0.05 vs Group O.
Table 2 The mean LH levels of 4 period after the icv administration
Group
LH level
(ng/ml)
6-30 min. 36-60 min. 66-90 min. 96-120 min.
Group C 8.940.83 7.300.74 7.750.87 8.240.61
Group O 5.500.80* 4.471.00** 6.010.73 5.620.81**
Group ON 8.600.89a 6.130.70 6.290.99 6.700.77
Note. Values are expressed as meansSEM.
* : p0.01 compared with group C, ** : p0.05 compared with group C. a : p0.05 compared with group O.
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vs Group O, p0.05, respectively) ; however, the
pulse frequency were still significantly lower than
in Group C (p0.05, respectively). No significant
differences were observed in the pulse amplitude
of the 3 groups.
Figure 4 : Effect of the icv administration of NPY antibody before orexin A on the pulsatile LH secretion in ovariectomized rats.
Values are expressed as the meanstandard error of mean (SEM). * : p0.01, ** : p0.05 (one way analysis of variance followed
by Fisher’s protected lest significance difference test.)
Figure 3 : Effect of the icv administration of NPY antibody before orexin A on the pulsatile LH secretion in ovariectomized rats.
The representive profiles of 2 rats treated with orexin A or saline at 0 min and preinjection of NPY antibody or NRS at -10 min. Open
reverse triangle () denotes a pulse of LH secretion.
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DISCUSSION
The reproductive function is restrained if energy
storage is insufficient for the maintenance of indi-
vidual life and the conservation of species. In fast-
ing condition, female animals show restrained es-
trous cycle and sexual behavior (14, 15). Therefore,
the neurons that regulate appetite and nutritional
state may influence GnRH secretion and control re-
productive function ; NPY would be the key peptide
that serves as a link between orexinergic informa-
tion from orexin and leptin and the signals (origi-
nating from the medulla oblongata) from the vagus
nerve (16). Orexins, also known as hypocretins,
were discovered and named based on their orexiner-
gic effect. Thereafter, orexins have been reported
to exert several effects, such as the stimulation of
activities, control the sleep-wake cycle, influence the
immune, autonomic, and neuroendocrine systems
(17) and the suppression of gonadotropin secretion.
With regard to the regulation of feeding activities,
fasting induces the expression of prepro-orexin
mRNA, which is a precursor of orexin in rat hypo-
thalamus (3), and orexin increases food intake
through NPY expression in the hypothalamic ARC
(18). However, the mechanisms of the other func-
tions of orexin, including the suppression of gona-
dotropin secretion, have not been completely clari-
fied.
In the present study, the icv injection of orexin A
stimulated food intake and suppressed gonadotro-
pin secretion in OVX rats, which is in agreement
with the results of previously published reports
(5, 7). Pretreatment with NPY antibody completely
neutralized the orexinergic effect of orexin A, which
was consistent with the previously reported findings
(19), indicating that the orexinergic effect of orexin
A is mediated by NPY. Furthermore, pretreatment
with NPY-Ab partially neutralized the suppressive
effect of orexin A on LH secretion in OVX rats, in-
dicating that this effect is also mediated by NPY, and
recovery was observed in not only the serum LH
level but also the frequency of pulsatile LH secre-
tion. Because LH pulses are generated by GnRH
pulses, the recovery of pulsatile LH frequency indi-
cated that pulsatile GnRH release was restored by
NPY-Ab. Therefore, the suppressive effect of orexin
A on GnRH secretion appeared to be mediated by
NPY in hypothalamus.
NPY plays an important role in energy homeo-
stasis and regulation of food intake ; the cell body
of this neuron is located mainly in the ARC. The
fibers of the NPY neuron of ARC are projected into
both the preoptic area (POA), which contains the
GnRH neuron cell body, and into the medial basal
hypothalamus (MBH) that regulates the release of
GnRH, which contains GnRH neuron fibers [20].
NPY Y1 receptor is present in the GnRH nerve
fibers in rats (20) and in GT-1 cells, which are the
stocking cells of GnRH (21). In ovarian steroid-
primed OVX rats, icv administration of NPY Y1 re-
ceptor antagonist suppressed the release of LH (22),
which suggested that NPY may influence GnRH via
the NPY Y1 receptor.
Action of NPY on the gonadotropin secretion dif-
fers depending on the presence or absence of es-
trogen. In vivo experiments suggested that NPY pro-
moted LH secretion, in the case of pretreatment
with estradiol, although NPY icv administration sup-
pressed the pulsatile secretion of LH in OVX rats
(23). The action of orexin on gonadotropin secretion
is similar to that of NPY. Pulsatile LH secretion and
serum LH levels are suppressed by icv injection of
orexin in OVX rats (5, 24). However, serum LH
level is elevated by icv injection of orexin in OVX
rats supplemented with estradiol (23). GnRH re-
lease from the brain cells of adult female rats dur-
ing pro-estrus are promoted by orexin (25). In this
way, both NPY and orexin suppress the pulsatile
secretion of GnRH and the basal secretion of gona-
dotropin and stimulate GnRH surge just before ovu-
lation. This similarity in the effects of NPY and
orexin suggests that the pathway of the action of
orexin on GnRH is similar to that of NPY. NPY
knockout (KO) mice do not show accelerated sex-
ual development. However, unlike wild type mice,
these mice do not show abnormal feeding behavior
and body weight and become hyperphagic after food
deprivation (26). Interestingly, although the activa-
tion of Y1 and Y5 receptors is involved in NPY-
induced hyperphagia, the Y1-KO and Y5-KO mice
develop late-onset obesity with increase in food in-
take and adiposity (27), whereas NPY-KO mice do
not show any change in the feeding behavior or
body weight. The compensation against the orexi-
genic NPY system, which would exist in these KO
mice, has not been elucidated thus far.
Two mechanisms have been proposed for the sup-
pression of reproductive function in the fasted state.
One is the activation of the network of feeding regu-
lators in the hypothalamus, which suppress the pul-
satile secretion of GnRH. The other is the attenu-
ation of the stimulatory effect of leptin on kisspeptin,
which is a potent stimulator of GnRH secretion (28).
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In the case of the former mechanism, NPY would
be an important factor involved in the suppression
of GnRH release by serving as a link in the acti-
vated network of the feeding regulators, including
orexin. Further, we have clarified the pathway by
which orexin A suppresses LH secretion through
β -END (7), CRH, and urocortin 2 (8). By combin-
ing this result with the results of the present study,
it can be suggested that orexin suppresses GnRH
secretion in the hypothalamus via several pathways
involving β -END, CRH, urocortin 2, and NPY.
In conclusion, NPY partially mediates the suppres-
sive effect of orexin on pulsatile LH secretion and
influences the orexinergic effect of orexin in OVX
rats. The mechanism of this effect consists of a net-
work of orexinergic neuropeptides that when acti-
vated would suppress reproduction in energy-defi-
cient conditions
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